Donor Focus The Cure GM1 Foundation operates with extremely low overhead and prioritizes directing the maximum possible funding toward research, indicating a strong donor efficiency story that can be leveraged in fundraising engagement and sponsorship discussions with potential corporate partners.

Recent Fundraising Momentum Significant recent closeouts with $40k and $76k raised at end of 2023 demonstrate growing donor engagement and potential for ongoing campaigns or event-based partnerships to accelerate funding toward GM1 research.

Tech & Accessibility Adoption of Zoom subtitle translation in 28 languages reflects a commitment to global accessibility and inclusive events, presenting an opportunity to pitch international collaboration, multi-language sponsorships, and broader dissemination of research findings.

Research Infrastructure Launch of a GM1 biorepository in collaboration with COMBINEDBrain signals a focus on cutting-edge research infrastructure, offering a compelling use case for industry partnerships, data-sharing initiatives, and sponsored research programs.

Market Position Operating in the rare disease space with a lean team, a revenue scale in the low-to-mid millions, and a mission-driven narrative, the foundation presents a prime partner for strategic grants, grant-funded programs, and collaboration with larger patient advocacy and biotech ecosystems.